Fondaparinux

Links shared publicly online about this topic

Low-dose Fondaparinux Not Safer for Non-STEMI Patients

hcplive.com — “Low-dose fondaparinux did not result in significant reductions in bleeding rate or complications in non-STEMI patients compared with a standard dose.View full resource at hcplive.com

  • View Related
  • Share

Most Recently Shared on September 7, 2010 at 3:14 pm By:

HCPLive_Cardio HCPLive_Cardio Cardiology

Low-dose Fondaparinux Not Safer for Non-STEMI Patients http://hcp.lv/bbIWEa

2 years ago...

Fondaparinux effective for superficial thrombosis but at very high cost - JAAPA

jaapa.com — “Clinical question Is fondaparinux safe and effective for the treatment of superficial-vein thrombosis?View full resource at jaapa.com

  • View Related
  • Share

Most Recently Shared on December 3, 2010 at 3:02 pm By:

JAAPAcom JAAPA Medical Journal

Fondaparinux effective for superficial thrombosis but at very high cost: Clinical question Is fondaparinux safe ... http://bit.ly/fIzDs1

1 year ago...

Family Med Medical News about Acute Coronary Syndrome Fondaparinux

mdlinx.com — “Fondaparinux and acute coronary syndromes: update on the OASIS 5"6 studiesView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 1, 2010 at 4:00 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Fondaparinux and acute coronary syndromes: update on the OASIS 5–6 studies: Vascular Health and Risk Ma... http://bit.ly/cHKf3w #GM #mdlinx

2 years ago...

Emisphere Technologies And Alchemia To Research An Oral Formulation Of Fondaparinux With Eligen(R) Technology

medicalnewstoday.com — “Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) announced that they are joining efforts to develop an oral formulation of the anti-coagulant drug fondaparinux with Emisphere'View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 21, 2010 at 12:17 pm By:

Health_Feed Health Feed Health News

Emisphere Technologies And Alchemia To Research An Oral Formulation Of Fondaparinux With Eligen(R) Technology http://ow.ly/16R5rF

2 years ago...

Fondaparinux Cuts Risks of SVT Leg Thrombosis (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- Treatment with the factor Xa inhibitor fondaparinux was effective in preventing complications in patients with acute superficial-vein thrombosis of the legs, an international double-blind study found.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on September 22, 2010 at 10:00 pm By:

MedicalFeed MedicalFeed Health News Feed

Fondaparinux Cuts Risks of SVT Leg Thrombosis (CME/CE): (MedPage Today) -- Treatment with the factor Xa inhibitor ... http://bit.ly/aLP9HA

2 years ago...

The Safety Of Two Intravenous Heparin Doses As Adjunct To PCI In ACS Patients Treated With Fondaparinux, Results From The FUTURA/OASIS 8 Trial

medicalnewstoday.com — “Results from the FUTURA/OASIS 8 study presented at the ESC Congress provide initial evidence that a low dose of unfractionated heparin does not reduce the incidence of bleeding or vascular complicView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 1, 2010 at 12:00 pm By:

mnt_blood MNT Blood Health News

The Safety Of Two Intravenous Heparin Doses As Adjunct To PCI In ACS Patients Treated With Fondaparinux, Results From ... http://mnt.to/3J6j

2 years ago...

Blocked

theannals.com — “BlockedView full resource at theannals.com

  • View Related
  • Share

Most Recently Shared on October 8, 2009 at 11:20 pm By:

theannals The Annals Medical Journal

Fondaparinux and the Management of Heparin-Induced Thrombocytopenia: The Journey Continues: Allison Beck Blackm.. http://bit.ly/3liqh3

3 years ago...

Using Lower-Dose Heparin During Percutaneous Coronary Intervention Does Not Appear To Reduce The Risk Of Major Bleeding

medicalnewstoday.com — “Patients with acute coronary syndromes initially treated with the anticoagulant fondaparinux who underwent a coronary procedure (such as balloon angioplasty) and received a lower dose of the anticView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 8, 2010 at 3:00 pm By:

mnt_cardiovasc MNT Cardiovascular Health News

Using Lower-Dose Heparin During Percutaneous Coronary Intervention Does Not Appear To Reduce The Risk Of Major Bleeding http://mnt.to/3JqF

2 years ago...

Blood Clot Treatment in Cancer Patients

medindia.net — “Cancer patients with blood clots gain no benefit from inferior vena cava filter (IVCF) placement to the anticoagulant medication fondaparinux, finds research.View full resource at medindia.net

  • View Related
  • Share

Most Recently Shared on July 8, 2011 at 5:45 pm By:

Rheumatology Article | Deep venous thrombosis

mdlinx.com — “Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after cemented total hip replacement: a comparative studyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 20, 2011 at 3:06 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after c... http://bit.ly/n8AVpb #Rheumatology

10 months ago...

Cardiology Article | Acute Coronary Syndrome

mdlinx.com — “Comparison of safety and efficacy between fondaparinux and nadroparin in non-ST elevation acute coronary syndromesView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 18, 2011 at 6:08 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Comparison of safety and efficacy between fondaparinux and nadroparin in non-ST elevation acute coro... http://bit.ly/i4i4bZ #cardiology

1 year ago...

Arixtra Starter Kits may contain recalled Triad alcohol prep pads - MPR

empr.com — “GlaxoSmithKline is notifying healthcare professionals and patients that Arixtra (fondaparinux sodium) Starter Kits may contain recalled Triad Group alcohol prep pads.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on January 24, 2011 at 10:05 pm By:

eMPR MPR Medical Publisher

MPR News: Arixtra Starter Kits may contain recalled Triad alcohol prep pads: GlaxoSmithKline is notifying health... http://bit.ly/g8BRgh

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related WisdomCards

Featuring the top 3 experts for this topic

  • HCPLive_Cardio

    HCPLive_Cardio

    Your online destination for Cardiology news,events,and resources

    View Profile

  • JAAPAcom

    JAAPA

    JAAPA is the peer-reviewed clinical journal of the American Academy of Physician Assistants.

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390